Richard Knox
Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.
Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.
Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.
He and his wife Jean, an editor, live in Boston. They have two daughters.
-
Two new drugs for hepatitis C can save lives. They are also wildly expensive, costing $66,000 to $84,000 per person. Insurers face paying billions for treatment, or explicitly rationing vital care.
-
As many as 5 million Americans have hepatitis C, and new drugs can cure almost all of them. But patients worry they won't get these expensive treatments in time.
-
Alarms are good and necessary things in hospital care — except when there are so many that caregivers miss signals of a patient in crisis. Trying to conquer "alarm fatigue," one hospital turned off the beeps — and found that patient care actually improved.
-
The question of how to treat ductal carcinoma in situ is roiling the medical profession, and making for tough choices for women. The condition may never become invasive cancer. But some women choose to have mastectomies rather than live with uncertainty.
-
Officials in Sheboygan, Wis., scrambled to contain a deadly, drug-resistant form of tuberculosis. An outbreak there serves as a reminder that the contagious disease still poses a threat in the U.S. Treating just nine cases will take months and cost millions of dollars.
-
At issue is a controversial study of more than 1,300 severely premature infants that looked at how much oxygen they should receive after birth. This spring, the federal Office for Human Research Protections criticized the scientists who ran the study for failing to tell parents enough about the risks.
-
Tuberculosis is much less of a health threat in the United States than it is in other countries. But a family in Boston discovered that even here, no one is immune from this ancient foe. More than a dozen family members were infected with TB, and matriarch Judy Williams died at age 59.
-
Those people who have contracted the H7N9 virus have become very sick. And unlike the older bird flu virus, this one shows some adaptation to mammals, making it a matter of concern. But it doesn't make chickens sick, posing unique difficulties in fighting this kind of flu.
-
An international team of disease detectives are in China to investigate an outbreak of a new strain of bird flu, H7N9. The biggest puzzle right now is where these infections are coming from, as testing poultry has turned up very few infected birds.
-
Many injured patients remain in intensive care and in critical condition, which means their condition could still tip toward recovery or death.